Member Info for Robsaunders99

Still drilling to TD

For once, they are keeping us updated

you can’t make this up, what a **** show and this clown winnifrith pumping the **** out of this stock

I think it’s over this time. The rat hasn’t got a chance of getting this refinanced.

Fact.

How big is it still,? Humongous

And take back this Company at this low value ?

Once Anavio have satisfied their option, does Arthur come back, kick Tom out, as there is clearly a power struggle there, get the JV back on with the major oil company and start the gas being pumped again.

Watching this space with eager.

It certainly is not over by a long way.

You need to add in another $1m of recurring revenues

Now the deals need to come in to support the cash burn here with this settlement

BOOM !!! The shackles have been taken off.....

I must not lie, I must not lie, I must not lie, I must not lie, I must not lie, I must not lie, I must not lie, I must not lie,must not lie, I must not lie, I must not lie, I must not lie, I must not lie, I must not lie, I must not lie, I must not lie,

sucking singh's sorry sattars **** !!!

You talk such a lot of rubbish.

I Know Levi personally, he is probably once of the most respected operators in this sector, and has huge contacts within his network.

I know for a fact there are certain deals that have been lined up and contracts are due to be signed very shortly.

Get your facts right rather than misleading people

Yes had it yesterday, here it is

ANGLE has announced a pivotal contract with Eisai Inc for a pilot study involving ANGLE’s

Portrait HER2 assay in a Phase II study of the HER2 targeting antibody-drug conjugate, BB-

1701. This is both a valuable contract, worth $250,000 over the study’s duration, but also

marks a significant milestone for ANGLE, offering potential for extensive follow-up studies

and establishing a promising collaboration with a major company in the pharmaceutical

industry.

● First large pharma collaboration: This contract represents ANGLE’s first large

pharmaceutical deal, with Eisai Inc generating more than £4bn in annual sales. Eisai has a

global stature and strong pipeline emphasis on oncology, and the success of this pilot study

could lead to numerous large-scale projects, signifying a substantial opportunity for growth

and market expansion for ANGLE.

● The significance of BB-1701: BB-1701, co-developed by Eisai and Bliss Biopharmaceutical as

part of a notable $2bn deal, is a novel therapeutic in the realm of HER2 targeting antibodydrug

conjugates (ADCs). This new class of compounds is revolutionising breast cancer

treatment, offering targeted, potent treatment while minimising impact on healthy tissues.

Comment: This contract with Eisai Inc represents a landmark achievement for ANGLE,

signifying its entry into high-profile pharmaceutical collaborations and the potential for a

transformative impact in oncology therapeutics. While ANGLE’s approach remains novel and

hence less likely to be trialled during periods of weak biotech funding, we continue to think it

offers significant potential in one of the most attractive cancer diagnostics niches, and with a

fresh commercial muscle, products and now strong validation, the shares could trade very

well as biotech funding recovers.

● We arrive at our 120p price target using a risk-adjusted NPV (rNPV) to value each of ANGLE's

opportu

Placees were pumping this all week, and retail fell for it.

As soo as they had a clear 25% - dunp !!

Hope not too many of you got burnt !!

Asher still cannot be trusted

Let’s wait now for the delays

Can someone send a link

Harry keep my name pinned here as I am a substantial holder.

If it goes down let’s chat and we can discuss a way forward

Tx

and that’s it, no extra funds for a drill breakdown or a weather delay.

this stock is just shocked, .25 looks cheap on paper, but in reality is still expensive expensive.

they ****ed up the business, no end here

Spot on my dear friend taken from the placing presentation

$3.2m dollars needs to be taken off the placing price.

There is also a chance that if they don’t pay this that the company can issue a default notice , and then helium are in serious trouble

The market in the US does not trade, there is very light volume out there, hence why you only have the small percentage full

pointless as it will gap open in the morning to at least .25 and maybe lower. the best stop loss. i would suggest is to try it at .32 and see if you get filled.

you can then buy them back at .25 or around there or maybe lower?

it will be a **** fest in the morning, with so much stock being washed into the market, and a thin market to being christmas

i can seriously see this at .20 this time of year